v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Cash flows from operating activities      
Net income $ 9,432 $ 9,560  
Adjustments to reconcile net income to net cash provided by (used in) operating activities      
Depreciation, amortization and accretion 46,863 39,600  
Deferred tax expense 2,394 2,486  
Gain on disposal of property and equipment and divestitures (405) (1,365)  
Equity in losses (earnings) of unconsolidated entities 290 (95)  
Credit loss expense 737 514  
Amortization and write off of debt issuance costs 413 998  
Inventory adjustments 98 (40)  
Equity-based compensation 5,825 3,481  
Impairments and abandonments 5,708 1,148  
Other operating items, net 598 487  
Changes in operating assets and liabilities      
Accounts receivable (54,479) (57,117)  
Prepaid expenses and other assets 2,100 (8,666)  
Accounts payable and accrued liabilities (9,332) 3,948  
Net cash provided by (used in) operating activities 10,242 (5,061)  
Cash flows from investing activities      
Purchase of property and equipment (78,377) (48,427)  
Purchase of equity-method investment   (72,059)  
Acquisitions, net of cash received (210) (13,980)  
Proceeds received from sales of property and equipment 1,056 1,944  
Net cash used in investing activities (77,531) (132,522)  
Cash flows from financing activities      
Borrowings from revolving line of credit 43,500 40,000  
Payments on revolving line of credit (113,500) (125,000)  
Borrowings from long-term debt   250,000  
Payments of finance lease obligations (158) (89)  
Payment of debt issuance costs   (7,352)  
Net proceeds from underwritten offering 191,705    
Dividends and distributions paid (8,752) (8,567)  
Payments under tax receivable agreements   (77)  
Contributions from noncontrolling interests   2,875  
Repurchase of common stock (7,618) (6,291)  
Net cash provided by financing activities 105,177 145,499  
Effect of exchange rate changes on cash (2) (2)  
Net increase in cash and cash equivalents 37,886 7,914  
Cash and cash equivalents, beginning of period 18,084 19,978 $ 19,978
Cash and cash equivalents, end of period 55,970 27,892 $ 18,084
Supplemental cash flow disclosure:      
Cash paid for interest 6,469 4,723  
Cash (refunds) paid for income taxes, net (24) 11  
Supplemental disclosure of noncash investing activities:      
Capital expenditures included in accounts payable and accrued liabilities $ 23,308 $ 62,370